TSS
EDIT icon

Two Sigma Securities’s Editas Medicine EDIT Stock Holding History

Two Sigma Securities’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-11,800
Closed -$827K – 1086
2020
Q4 		$827K Buy
+11,800
New +$485K 0.02% 468
2020
Q1 		– Sell
-12,200
Closed -$361K – 1594
2019
Q4 		$361K Buy
+12,200
New +$305K ﹤0.01% 1666

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Two Sigma Securities's EDIT Position: Q1 2026 in Review

Two Sigma Securities reduced its Editas Medicine (EDIT) stake by 76% in Q1 2026, selling an estimated $70.7K and leaving 10,459 shares worth $25.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1338.

Two Sigma Securities first reported a position in EDIT in Q4 2019 and has held it in 5 quarters since. The position peaked at $952K in Q4 2019. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Two Sigma Securities held 10,459 shares of Editas Medicine worth $25.8K as of Q1 2026.
  • Two Sigma Securities sold 33,411 Editas Medicine shares in Q1 2026, an estimated $70.7K.
  • Editas Medicine made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1338 holding.
  • Two Sigma Securities first reported a position in Editas Medicine in Q4 2019 and has held it in 5 quarters since.
  • Two Sigma Securities's Editas Medicine position peaked at $952K in Q4 2019.
  • 208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.